tiprankstipranks
Tony G Holdings Announces Alclin’s Key Milestones
Company Announcements

Tony G Holdings Announces Alclin’s Key Milestones

Story Highlights

Tony G Co-Investment Holdings Ltd (TSE:TONY) has released an update.

Don't Miss Our Christmas Offers:

Tony G Co-Investment Holdings Ltd. announces significant progress for Alclin, a company in its investment portfolio, as it secures overseas site registration and a drug registration for its NAD+ product. Alclin has also increased its production capacity significantly and received a license from South Africa’s regulatory authority to manufacture, import, and export its growing product range. This marks a key development in their strategy focused on longevity products.

For further insights into TSE:TONY stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskTony G Co-Investment Holdings Updates on Legal Proceedings
TipRanks Canadian Auto-Generated NewsdeskTony G Co-Investment Holdings Restructures Leadership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App